Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
复制标题
DOI:
10.3389/fimmu.2018.00979
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Borkhardt A
中科院分区:
文献类型:
--
作者:
Ghosh S;Drexler I;Bhatia S;Adler H;Gennery AR;Borkhardt A
Patients with primary immunodeficiency can be prone to severe Epstein–Barr virus (EBV) associated immune dysregulation. Individuals with mutations in the interleukin-2-inducible T-cell kinase (ITK) gene experience Hodgkin and non-Hodgkin lymphoma, EBV lymphoproliferative disease, hemophagocytic lymphohistiocytosis, and dysgammaglobulinemia. In this review, we give an update on further reported patients. We believe that current clinical data advocate early definitive treatment by hematopoietic stem cell transplantation, as transplant outcome in primary immunodeficiency disorders in general has gradually improved in recent years. Furthermore, we summarize experimental data in the murine model to provide further insight of pathophysiology in ITK deficiency.
登录
查看更多内容
影响因子:
16.6
作者:
Gomez-Rodriguez J;Meylan F;Handon R;Hayes ET;Anderson SM;Kirby MR;Siegel RM;Schwartzberg PL
通讯作者:
Schwartzberg PL
DOI:
10.1084/jem.20151110
发表时间:
2016-06-27
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Keller B;Zaidman I;Yousefi OS;Hershkovitz D;Stein J;Unger S;Schachtrup K;Sigvardsson M;Kuperman AA;Shaag A;Schamel WW;Elpeleg O;Warnatz K;Stepensky P
通讯作者:
Stepensky P
影响因子:
6.4
作者:
Bienemann, Kirsten;Borkhardt, Arndt;Oschlies, Ilske
通讯作者:
Oschlies, Ilske
影响因子:
11.4
作者:
Linka, R. M.;Risse, S. L.;Borkhardt, A.
通讯作者:
Borkhardt, A.
DOI:
10.4049/jimmunol.1601202
发表时间:
2017-04-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kapnick SM;Stinchcombe JC;Griffiths GM;Schwartzberg PL
通讯作者:
Schwartzberg PL